Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 37

Results For "HR"

5856 News Found

Sanofi India appoints Rodolfo Hrosz as new Managing Director
People | April 18, 2022

Sanofi India appoints Rodolfo Hrosz as new Managing Director

Rodolfo brings with him a wealth of rich experience from commercial, marketing, and general management roles across several multinational companies


Juniper Biologics acquires cell-mediated gene therapy for treatment of knee osteoarthritis
Healthcare | April 13, 2022

Juniper Biologics acquires cell-mediated gene therapy for treatment of knee osteoarthritis

The US $600 million acquisition will see Juniper Biologics offer the world's first cell-mediated gene therapy to an estimated 300 million patients in Asia Pacific, Middle East and Africa


Israel’s TAU breakthrough offers new hope to help people with paralysis walk again
News | April 11, 2022

Israel’s TAU breakthrough offers new hope to help people with paralysis walk again

Researchers from the Tel Aviv University successfully engineer the world's first 3D human spinal cord tissue transplant


Cadila Pharma launches world’s first three-dose rabies vaccine
News | April 08, 2022

Cadila Pharma launches world’s first three-dose rabies vaccine

The recombinant nanoparticle-based rabies G protein vaccine is prepared using virus-like particle technology.


Good business performance gives Boehringer Ingelheim tailwind for investment in R&D
Biotech | April 05, 2022

Good business performance gives Boehringer Ingelheim tailwind for investment in R&D

R&D investment up 11.7% to 4.1 billion EUR in 2021 (20.0% of net sales)


Dr Shravan Subramanyam, MD, Wipro GE Healthcare elected NATHEALTH President
News | April 01, 2022

Dr Shravan Subramanyam, MD, Wipro GE Healthcare elected NATHEALTH President

Highlights the need for rebuilding, restructuring, and re-imagining resilient healthcare systems in India


Pfizer granted USFDA Breakthrough Therapy Designation for RSV vaccine candidate
Drug Approval | March 24, 2022

Pfizer granted USFDA Breakthrough Therapy Designation for RSV vaccine candidate

The FDA decision is primarily informed by the positive results of a proof-of-concept, Phase 2a study evaluating the safety, immunogenicity, and efficacy of a single dose of 120µg RSVpreF in a human viral challenge model in healthy adults 18 to 50 years of age


Lonza appoints Christian Seufert as President of CHI Division
People | March 23, 2022

Lonza appoints Christian Seufert as President of CHI Division

Christian brings a unique level of experience and expertise from a 20-year career at BASF across multiple territories and businesses


Boehringer Ingelheim and the World Association for Buiatrics support research on ruminant animal health
News | March 22, 2022

Boehringer Ingelheim and the World Association for Buiatrics support research on ruminant animal health

Submissions for Ruminant Well-Being Awards and Gustav Rosenberger Memorial Fund grant open now


Nipah survivors study to advance new vaccines against highly fatal threat
Biotech | March 16, 2022

Nipah survivors study to advance new vaccines against highly fatal threat

CEPI will expand its partnership with icddr,b in Bangladesh, providing near to the additional US $ 1 million in funding to advance understanding of the Nipah virus